Spyre Therapeutics Inc

NEW
FRA:3920 (USA)  
€ 88.5 +3 (+3.51%) Jul 31
At Loss
P/B:
15.05
Market Cap:
€ 7.41B ($ 8.55B)
Enterprise V:
€ 6.90B ($ 7.96B)
Volume:
200.00
Avg Vol (2M):
135.00
Trade In:

Spyre Therapeutics Inc (FRA:3920) Dividend

Spyre Therapeutics Inc (FRA:3920) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -210.4%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:3920 Dividend

Does Spyre Therapeutics Inc (FRA:3920) pay a dividend?

Spyre Therapeutics Inc (FRA:3920) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Spyre Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Spyre Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -210.4% over the past 3 years.

What are dividend-paying alternatives to Spyre Therapeutics Inc?

For dividend-paying alternatives in Spyre Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.